Sign In

James Healy

General Partner and President at Sofinnova Ventures

Dr. James Healy is a renowned Medical Scientist and Biotechnology Investor with over 20 years of experience in funding groundbreaking therapies.

Currently serving as the Managing Partner and Chairman of Sofinnova Investments, Dr. Healy has a successful track record with numerous investments resulting in FDA or EMA approvals, as well as public offerings and acquisitions.

His notable investments and board memberships include companies like Amarin, Apellis, Audentes, Tesaro, and many more.

Dr. Healy has been recognized with several prestigious awards for his contributions to the biotech industry, including the IBF Innovator Award and the National Venture Capital Association Excellence in Healthcare Innovation Award.

He holds a B.A. in Molecular Biology and B.A. Scandinavian Studies from UC Berkeley, in addition to MD and PhD degrees in Immunology from Stanford University.

An accomplished author with multiple scientific publications, Dr. Healy has also lectured on entrepreneurship at Stanford University and held various board positions in organizations like Biotechnology Innovation Organization and National Venture Capital Association.

J
Add to my network

Location

Menlo Park, California